Ketamine Biomarker Validation

NCT07307768 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Depression (TRD)

Interventions

DRUG: Ketamine (0.25 mg/kg)
DRUG: Ketamine (0.5 mg/kg)
DRUG: Ketamine (0.75 mg/kg)

Sponsor

Soterix Medical

Collaborators

[object Object]